Study number 780140
Call to Schedule Your Screening Appointment!
Dates
Jan 21 2026-May 14 2026
Location
Daytona Beach, Florida
Age
18-75
Gender
Male OR Female
Smoker
Yes
Compensation
$14,800
Group
3Ba
Study Details
The investigational drug in this research study is being developed for the potential treatment of various autoimmune disorders, which are conditions where the immune system does not work properly.
Daytona Beach, FL is currently recruiting Healthy Males and Females of Non-Childbearing Potential, ages 18-75.
Refer a friend & receive $350 per qualified referral
Women Eligibility Criteria
- Women must be non-childbearing potential
- Permanently sterile at least 6 weeks prior to screening:
- hysterectomy
- bilateral oophorectomy
- bilateral salpingectomy
- Postmenopausal
- Permanently sterile at least 6 weeks prior to screening:
Body Mass Index
- Participants must have a BMI of:
- 18-32
Smoking criteria
- Smoking is not allowed.
Screening procedures
- Screening procedures for this study may include:
- Vitals
- Physical examination
- Electrocardiogram (ECG)
- Collection of blood samples
- Drug and Alcohol testing
- Chest X-ray
Additional Details
Call Now to Schedule Your Screening Appointment!
Group 3Ba:
Check-in: Jan 21
Check-out: Jan 28
Follow up Visits: Feb 1, 5, 12, 19 Mar 5, 19, Apr 2, 16, May 14